Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M844Revenue $M94.3Net Margin (%)-32.8Altman Z-Score2.6
Enterprise Value $M777EPS $-0.4Operating Margin %-30.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score157Pre-tax Margin (%)-32.8Higher ROA y-yY
Price/Book9.510-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsN
Price/Sales8.05-y EBITDA Growth Rate %-45.7Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-55.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M85.7ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBRonald Muhlenkamp 2015-12-31 Sold Out -0.01%$6.13 - $13.45
($9.11)
$ 9.858%Sold Out0
PACBRonald Muhlenkamp 2015-09-30 Buy 0.01%$3.66 - $5.8
($4.89)
$ 9.85101%New holding11,125
PACBFirst Eagle Investment 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.96)
$ 9.85403%Sold Out0
PACBFirst Eagle Investment 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 9.85165%New holding150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 9.8525%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 9.85-17%New holding10,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phillips James MichaelSVP, Research & Development 2016-04-25Sell20,000$10.29-4.28view
Phillips James MichaelSVP, Research & Development 2015-08-07Sell16,689$4.61113.67view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.91100.61view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.91100.61view
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.91100.61view
Ericson William W.Director 2014-08-19Buy39,299$5.1491.63view
Ericson William W.Director 2014-08-18Buy135,155$5.0993.52view
Ericson William W.Director 2014-08-14Buy77,822$597view
Ericson William W.Director 2014-08-13Buy29,435$4.9399.8view
Ericson William W.Director 2014-08-12Buy123,423$4.89101.43view

Quarterly/Annual Reports about PACB:

News about PACB:

Articles On GuruFocus.com
Meridian Funds Comments on Pacific Biosciences of California Inc. Mar 08 2016 
Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

More From Other Websites
ETF’s with exposure to Pacific Biosciences of California, Inc. : April 26, 2016 Apr 26 2016
Billionaire Andreas Halvorsen Acquires New Stake in Rice Energy Inc. (RICE); Two Other Hedge... Apr 26 2016
Pacific Biosciences and Advanced Analytical Technologies Announce Co-Marketing Agreement Apr 26 2016
Pacific Biosciences and Advanced Analytical Technologies Announce Co-Marketing Agreement Apr 26 2016
Pacific Biosciences of California, Inc. :PACB-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 25 2016
Edited Transcript of PACB earnings conference call or presentation 21-Apr-16 8:30pm GMT Apr 22 2016
Pacific Biosciences (PACB) Stock Soars Following Q1 Results Apr 22 2016
Pacific Biosciences (PACB) Q1 Loss Narrower than Expected Apr 22 2016
Pacific Biosciences of California, Inc. Announces First Quarter 2016 Financial Results Apr 21 2016
Pacific Biosciences reports 1Q loss Apr 21 2016
Pacific Biosciences reports 1Q loss Apr 21 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Results of Operations and Financial... Apr 21 2016
Pacific Biosciences of California, Inc. Announces First Quarter 2016 Financial Results Apr 21 2016
Q1 2016 Pacific Biosciences of California Inc Earnings Release - After Market Close Apr 21 2016
What Awaits Pacific Biosciences (PACB) in Q1 Earnings? Apr 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)